Experimental Hematology
Volume 38, Issue 2 , Pages 116-123 , February 2010

Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-1106P induces a phenotype resembling the Hodgkin lymphoma cell line L1236

  • Erik Andersson

      Affiliations

    • Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Solna, Sweden
    • Orexo AB, Uppsala, Sweden
    • Corresponding Author InformationOffprint requests to: Erik Andersson, Ph.D., Orexo AB, Box 303, 751 05 Uppsala, Sweden
    • ,
  • Frida Schain

      Affiliations

    • Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Solna, Sweden
    • ,
  • Jan Sjöberg

      Affiliations

    • Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Solna, Sweden
    • ,
  • Magnus Björkholm

      Affiliations

    • Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Solna, Sweden
    • ,
  • Hans-Erik Claesson

      Affiliations

    • Orexo AB, Uppsala, Sweden
    • Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

Received 26 August 2009 ,Revised 23 October 2009 ,Accepted 16 November 2009.

References 

  1. Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851–862
  2. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871–3879
  3. Mani H, Jaffe ES. Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma. 2009;9:206–216
  4. Traverse-Glehen A, Pittaluga S, Gaulard P, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29:1411–1421
  5. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer. 2009;9:15–27
  6. Thomas RK, Re D, Wolf J, Diehl V. Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells. Lancet Oncol. 2004;5:11–18
  7. Eberle FC, Mani H, Jaffe ES. Histopathology of Hodgkin's Lymphoma. Cancer J. 2009;15:129–137
  8. Rodriguez J, Gutierrez A, Piris M. Primary mediastinal B-cell lymphoma: Treatment and therapeutic targets. Leuk Lymphoma. 2008;49:1050–1061
  9. Claesson H-E, Dahlen S-E. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs. J Intern Med. 1999;245:205–227
  10. Schain F, Tryselius Y, Sjoberg J, et al. Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma. Int J Cancer. 2008;123:2285–2293
  11. Schain F, Schain D, Mahshid Y, et al. Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas. Clin Lymphoma Myeloma. 2008;8:340–347
  12. Claesson HE. On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma. Prostaglandins Other Lipid Mediat. 2009;89:120–125
  13. Kuhn H, O'Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006;45:334–356
  14. Andersson E, Schain F, Svedling M, Claesson HE, Forsell PK. Interaction of human 15-lipoxygenase-1 with phosphatidylinositol bisphosphates results in increased enzyme activity. Biochim Biophys Acta. 2006;1761:1498–1505
  15. Claesson HE, Griffiths WJ, Brunnstrom A, et al. Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: Novel insight into the inflammatory features of classical Hodgkin lymphoma. FEBS J. 2008;275:4222–4234
  16. Feltenmark S, Gautam N, Brunnstrom A, et al. Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. Proc Natl Acad Sci U S A. 2008;105:680–685
  17. Skinnider BF, Kapp U, Mak TW. The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma. 2002;43:1203–1210
  18. LaPorte SL, Juo ZS, Vaclavikova J, et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell. 2008;132:259–272
  19. Wolf J, Kapp U, Bohlen H, et al. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood. 1996;87:3418–3428
  20. Poppema S, Kluiver JL, Atayar C, et al. Report: workshop on mediastinal grey zone lymphoma. Eur J Haematol. 2005;(Suppl l):45–52
  21. Skinnider BF, Elia AJ, Gascoyne RD, et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2002;99:618–626
  22. Skinnider BF, Elia AJ, Gascoyne RD, et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2001;97:250–255
  23. Guiter C, Dusanter-Fourt I, Copie-Bergman C, et al. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood. 2004;104:543–549
  24. Tangye SG, Ferguson A, Avery DT, Ma CS, Hodgkin PD. Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol. 2002;169:4298–4306
  25. Brinckmann R, Topp M, Zalan I, et al. Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4. Biochem J. 1996;318(Pt 1):305–312
  26. Brinckmann R, Kuhn H. Regulation of 15-lipoxygenase expression by cytokines. Adv Exp Med Biol. 1997;400B:599–604
  27. Conrad DJ, Lu M. Regulation of human 12/15-lipoxygenase by Stat6-dependent transcription. Am J Respir Cell Mol Biol. 2000;22:226–234
  28. Thivierge M, Stankova J, Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol. 2001;167:2855–2860
  29. Zhai Y, Zhong Z, Chen CY, et al. Coordinated changes in mRNA turnover, translation, and RNA processing bodies in bronchial epithelial cells following inflammatory stimulation. Mol Cell Biol. 2008;28:7414–7426
  30. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99:4283–4297
  31. Maggio E, van den Berg A, Diepstra A, et al. Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. Ann Oncol. 2002;13(Suppl 1):52–56
  32. Teruya-Feldstein J, Tosato G, Jaffe ES. The role of chemokines in Hodgkin's disease. Leuk Lymphoma. 2000;38:363–371

PII: S0301-472X(09)00430-5

doi: 10.1016/j.exphem.2009.11.005

Experimental Hematology
Volume 38, Issue 2 , Pages 116-123 , February 2010

Article Tools

* Image Usage & Resolution